To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With nAMD (NCT06022744) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2023-09-01 |
Track To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD automatically
Every clearance here is in the API, with alerts when new ones post.